Provided by Tiger Fintech (Singapore) Pte. Ltd.

VolitionRX

0.7844
+0.109416.21%
Volume:269.82K
Turnover:197.47K
Market Cap:80.81M
PE:-2.94
High:0.7900
Open:0.7051
Low:0.6800
Close:0.6750
Loading ...

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
09 Jul

Advancements in VolitionRX’s Diagnostic Technology and Promising Market Position

TIPRANKS
·
09 Jul

VolitionRx files to sell 23.44M shares of common stock for holders

TIPRANKS
·
04 Jul

VolitionRX Ltd. Unveils Strategic Update on Cancer Screening and Monitoring Advancements in Animal and Human Health

Reuters
·
24 Jun

VolitionRX Stockholders Approve Key Proposals at Meeting

TIPRANKS
·
21 Jun

VolitionRX Ltd. Conducted Annual Stockholders Meeting

Reuters
·
21 Jun

VolitionRX Ltd. President and CEO Cameron John Reynolds Acquires Common Shares

Reuters
·
16 Jun

BRIEF-Volition Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1 Concentrations Are Closely Associated With Sepsis And Organ Failure

Reuters
·
12 Jun

Volition Announces Mars Consortium Clinical Study Suggests Nu.q® H3.1. Concentrations Are Closely Associated With Sepsis and Organ Failure

THOMSON REUTERS
·
12 Jun

VolitionRx’s Strategic Positioning and Growth Potential Justifies Buy Rating

TIPRANKS
·
11 Jun

VolitionRX Initiated at Buy by Jones Trading

Dow Jones
·
10 Jun

VolitionRx initiated with a Buy at JonesResearch

TIPRANKS
·
10 Jun

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties

THOMSON REUTERS
·
05 Jun

Director Innes Guy Archibald Reports Acquisition of VolitionRX Ltd. Common Shares

Reuters
·
04 Jun

Chief Scientific Officer Jacob Vincent Micallef Reports Acquisition of Common Shares in VolitionRX Ltd

Reuters
·
20 May

VolitionRX Ltd. CEO Cameron John Reynolds Reports Acquisition of Common Shares

Reuters
·
20 May

VolitionRX (VNRX) Receives a Hold from Benchmark Co.

TIPRANKS
·
19 May

VolitionRX Q1 EPS $(0.06) Up From $(0.10) YoY, Sales $246.38K Up From $171.53K YoY

Benzinga
·
16 May

VolitionRx Ltd. Reports 44% Increase in Q1 2025 Revenue, Reaches Commercial Milestone with Nu.Q® NETs Sales in Europe

Reuters
·
16 May

Press Release: VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

Dow Jones
·
12 May